These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28012766)

  • 61. Should hilar lymph nodes be expected in radical nephrectomy specimens?
    Phan DC; McKenney JK; Cox RM; Madi R; Greene GF; Gokden N
    Pathol Res Pract; 2010 May; 206(5):310-3. PubMed ID: 20189726
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Surgical treatment of perplexing renal cell carcinoma].
    Lin Z; Chen S; Ye C
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):463-4. PubMed ID: 10920947
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of lymphadenectomy in renal cell carcinoma.
    Ditonno P; Traficante A; Battaglia M; Grossi FS; Selvaggi FP
    Prog Clin Biol Res; 1992; 378():169-74. PubMed ID: 1301578
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Tumor size and regional lymph node metastasis in patients with M0 renal cell carcinoma: analysis in those having regional lymph node dissection].
    Hashimoto K; Hisasue S; Yanase M; Takahashi A; Hisataki T; Kitamura H; Masumori N; Itoh N; Tsukamoto T
    Hinyokika Kiyo; 2005 Sep; 51(9):621-5. PubMed ID: 16229376
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The rationale and the role of lymph node dissection in renal cell carcinoma.
    Capitanio U; Leibovich BC
    World J Urol; 2017 Apr; 35(4):497-506. PubMed ID: 27364520
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Editorial comment.
    Pomara G; Francesca F
    Urology; 2011 May; 77(5):1146; author reply 1146-7. PubMed ID: 21539964
    [No Abstract]   [Full Text] [Related]  

  • 67. Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma.
    Kates M; Lavery HJ; Brajtbord J; Samadi D; Palese MA
    Ann Surg Oncol; 2012 Aug; 19(8):2693-9. PubMed ID: 22526899
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.
    Tilki D; Hu B; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chandrasekar T; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Linares E; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Thieu W; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
    J Urol; 2015 Feb; 193(2):436-42. PubMed ID: 25063493
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Renal cell carcinoma in children. Prognostic factors.
    Al-Shabanah MO; Jenkin DR; Khafaga YO; Al-Zahrani AM; Danjoux C; Greenberg M
    Saudi Med J; 2004 Nov; 25(11):1583-6. PubMed ID: 15573183
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
    Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2/pT3 or high-grade renal tumors compared with radical nephrectomy.
    Weight CJ; Lythgoe C; Unnikrishnan R; Lane BR; Campbell SC; Fergany AF
    Urology; 2011 May; 77(5):1142-6. PubMed ID: 21420154
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diagnostic accuracy of preoperative computed tomography used alone to detect lymph-node involvement at radical nephrectomy.
    Connolly SS; Raja A; Stunell H; Parashar D; Upponi S; Warren AY; Gnanapragasam VJ; Eisen T
    Scand J Urol; 2015 Apr; 49(2):142-8. PubMed ID: 25623950
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis.
    Capitanio U; Suardi N; Matloob R; Abdollah F; Castiglione F; Briganti A; Carenzi C; Roscigno M; Montorsi F; Bertini R
    BJU Int; 2013 Mar; 111(3):412-8. PubMed ID: 22703190
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The number of lymph nodes examined and staging accuracy in renal cell carcinoma.
    Terrone C; Guercio S; De Luca S; Poggio M; Castelli E; Scoffone C; Tarabuzzi R; Scarpa RM; Fontana D; Rocca Rossetti S
    BJU Int; 2003 Jan; 91(1):37-40. PubMed ID: 12614247
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection.
    Babaian KN; Kim DY; Kenney PA; Wood CG; Wong J; Sanchez C; Fang JE; Gerber JA; Didic A; Wahab A; Golla V; Torres C; Tamboli P; Qiao W; Matin SF; Wood CG; Karam JA
    J Urol; 2015 Apr; 193(4):1101-7. PubMed ID: 25390078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.